Don’t Miss Out on Pharma Industry Event of the Year
Michael L. Rutherford
The 2018 ISPE Annual Meeting and Expo is less than two weeks away and time is running out to register for the pharma event of the year. Philadelphia - the city of “Brotherly Love” – will host this year’s Annual Meeting and provide an amazing educational opportunity for all the attendees. The program includes four prominent keynote speakers, more than 50 technical education sessions and workshops, and one of our largest vendor exhibitions to-date. It is also a great opportunity to meet with vendors and colleagues and discuss the latest pharma industry trends, as well as learn about and get involved in ISPE by becoming a member, joining a Community of Practice (COP’s) or special interest group, volunteering, contributing to a guidance document and so much more. All of these opportunities will allow you to apply and further grow your career and bring back actionable knowledge to your company.
That is how I got involved with ISPE over 15 years ago – attending a meeting and presenting on an industry topic I was involved in that has since allowed me to expand my knowledge and influence within the industry. I personally believe the ISPE Annual Meeting to be one of the best opportunities to identify and establish new global contacts and expand my network of subject matter experts that I can reach out to when I have questions or need advice. With a significant pharmaceutical, engineering, medical, and biotech presence in Philadelphia, this is one conference I know you do not want to miss - there will be no better opportunity for you to learn and collaborate with others.
I encourage you to join me, industry colleagues, and regulatory experts at the 2018 ISPE Annual Meeting and Expo by leveraging the education option that best fits your schedule, which includes one-day, multi-day, or full conference registrations. Also, do not forget about the two days of ISPE training available after the conference on 8-9 November.
Retired, Computer Systems Quality & Data Integrity
Michael Rutherford is a retired pharmaceutical industry quality professional with almost 36 years of experience. In November 2023, he retired from Syneos Health as Executive...
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.